Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.26)
# 3,782
Out of 4,667 analysts
22
Total ratings
30%
Success rate
-27.13%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $72 → $68 | $27.71 | +145.40% | 2 | Oct 21, 2024 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.30 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $3.06 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $3.38 | +1,290.53% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $49 → $33 | $0.30 | +10,791.09% | 2 | Mar 28, 2023 | |
| ZYXI Zynex | Maintains: Buy | $27 → $28 | $7.86 | +256.23% | 1 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.57 | +5,632.48% | 1 | Aug 4, 2022 | |
| ECOR electroCore | Initiates: Buy | $45 | $9.94 | +352.72% | 1 | Jul 27, 2021 | |
| HROW Harrow | Initiates: Buy | $14 | $42.44 | -66.42% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.58 | +343.04% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $5.89 | +782.85% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11,025 | $0.51 | +2,159,970.53% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $7.50 | -6.67% | 1 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.77 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $70.69 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Oct 21, 2024
Maintains: Neutral
Price Target: $72 → $68
Current: $27.71
Upside: +145.40%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.30
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.06
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $3.38
Upside: +1,290.53%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $49 → $33
Current: $0.30
Upside: +10,791.09%
Zynex
Mar 28, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $7.86
Upside: +256.23%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.57
Upside: +5,632.48%
electroCore
Jul 27, 2021
Initiates: Buy
Price Target: $45
Current: $9.94
Upside: +352.72%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $42.44
Upside: -66.42%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.58
Upside: +343.04%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $5.89
Upside: +782.85%
Jun 26, 2020
Initiates: Buy
Price Target: $11,025
Current: $0.51
Upside: +2,159,970.53%
Sep 25, 2017
Initiates: Buy
Price Target: $7
Current: $7.50
Upside: -6.67%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.77
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $70.69
Upside: -